BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 26341081)

  • 1. High-throughput screening against thioredoxin glutathione reductase identifies novel inhibitors with potential therapeutic value for schistosomiasis.
    Li T; Ziniel PD; He PQ; Kommer VP; Crowther GJ; He M; Liu Q; Van Voorhis WC; Williams DL; Wang MW
    Infect Dis Poverty; 2015 Aug; 4():40. PubMed ID: 26341081
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis and evaluation of 1,4-naphthoquinone ether derivatives as SmTGR inhibitors and new anti-schistosomal drugs.
    Johann L; Belorgey D; Huang HH; Day L; Chessé M; Becker K; Williams DL; Davioud-Charvet E
    FEBS J; 2015 Aug; 282(16):3199-217. PubMed ID: 26111549
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of Lead Compounds Targeting the Selenoprotein Thioredoxin Glutathione Reductase for Treatment of Schistosomiasis.
    Lyu H; Petukhov PA; Banta PR; Jadhav A; Lea WA; Cheng Q; Arnér ESJ; Simeonov A; Thatcher GRJ; Angelucci F; Williams DL
    ACS Infect Dis; 2020 Mar; 6(3):393-405. PubMed ID: 31939288
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular docking to explore the possible binding mode of potential inhibitors of thioredoxin glutathione reductase.
    Huang J; Hua W; Li J; Hua Z
    Mol Med Rep; 2015 Oct; 12(4):5787-95. PubMed ID: 26239395
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Discovery of New Anti-Schistosomal Hits by Integration of QSAR-Based Virtual Screening and High Content Screening.
    Neves BJ; Dantas RF; Senger MR; Melo-Filho CC; Valente WC; de Almeida AC; Rezende-Neto JM; Lima EF; Paveley R; Furnham N; Muratov E; Kamentsky L; Carpenter AE; Braga RC; Silva-Junior FP; Andrade CH
    J Med Chem; 2016 Aug; 59(15):7075-88. PubMed ID: 27396732
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quantitative high-throughput screen identifies inhibitors of the Schistosoma mansoni redox cascade.
    Simeonov A; Jadhav A; Sayed AA; Wang Y; Nelson ME; Thomas CJ; Inglese J; Williams DL; Austin CP
    PLoS Negl Trop Dis; 2008 Jan; 2(1):e127. PubMed ID: 18235848
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fragment library screening by X-ray crystallography and binding site analysis on thioredoxin glutathione reductase of Schistosoma mansoni.
    de Souza Neto LR; Montoya BO; Brandão-Neto J; Verma A; Bowyer S; Moreira-Filho JT; Dantas RF; Neves BJ; Andrade CH; von Delft F; Owens RJ; Furnham N; Silva-Jr FP
    Sci Rep; 2024 Jan; 14(1):1582. PubMed ID: 38238498
    [TBL] [Abstract][Full Text] [Related]  

  • 8. QSAR-Driven Discovery of Novel Chemical Scaffolds Active against Schistosoma mansoni.
    Melo-Filho CC; Dantas RF; Braga RC; Neves BJ; Senger MR; Valente WC; Rezende-Neto JM; Chaves WT; Muratov EN; Paveley RA; Furnham N; Kamentsky L; Carpenter AE; Silva-Junior FP; Andrade CH
    J Chem Inf Model; 2016 Jul; 56(7):1357-72. PubMed ID: 27253773
    [TBL] [Abstract][Full Text] [Related]  

  • 9.
    Oyinloye BE; Shamaki DE; Agbebi EA; Onikanni SA; Ubah CS; Aruleba RT; Dao TNP; Owolabi OV; Idowu OT; Mathenjwa-Goqo MS; Esan DT; Ajiboye BO; Omotuyi OI
    Molecules; 2024 Apr; 29(9):. PubMed ID: 38731401
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Thioredoxin glutathione reductase from Schistosoma mansoni: an essential parasite enzyme and a key drug target.
    Kuntz AN; Davioud-Charvet E; Sayed AA; Califf LL; Dessolin J; Arnér ES; Williams DL
    PLoS Med; 2007 Jun; 4(6):e206. PubMed ID: 17579510
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of oxadiazoles as new drug leads for the control of schistosomiasis.
    Sayed AA; Simeonov A; Thomas CJ; Inglese J; Austin CP; Williams DL
    Nat Med; 2008 Apr; 14(4):407-12. PubMed ID: 18345010
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thioredoxin glutathione reductase as a novel drug target: evidence from Schistosoma japonicum.
    Song L; Li J; Xie S; Qian C; Wang J; Zhang W; Yin X; Hua Z; Yu C
    PLoS One; 2012; 7(2):e31456. PubMed ID: 22384025
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Investigations of the catalytic mechanism of thioredoxin glutathione reductase from Schistosoma mansoni.
    Huang HH; Day L; Cass CL; Ballou DP; Williams CH; Williams DL
    Biochemistry; 2011 Jul; 50(26):5870-82. PubMed ID: 21630672
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Macromolecular bases of antischistosomal therapy.
    Angelucci F; Miele AE; Boumis G; Brunori M; Dimastrogiovanni D; Bellelli A
    Curr Top Med Chem; 2011; 11(16):2012-28. PubMed ID: 21619508
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fragment-Based Discovery of a Regulatory Site in Thioredoxin Glutathione Reductase Acting as "Doorstop" for NADPH Entry.
    Silvestri I; Lyu H; Fata F; Boumis G; Miele AE; Ardini M; Ippoliti R; Bellelli A; Jadhav A; Lea WA; Simeonov A; Cheng Q; Arnér ESJ; Thatcher GRJ; Petukhov PA; Williams DL; Angelucci F
    ACS Chem Biol; 2018 Aug; 13(8):2190-2202. PubMed ID: 29800515
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Probing the Surface of a Parasite Drug Target Thioredoxin Glutathione Reductase Using Small Molecule Fragments.
    Fata F; Silvestri I; Ardini M; Ippoliti R; Di Leandro L; Demitri N; Polentarutti M; Di Matteo A; Lyu H; Thatcher GRJ; Petukhov PA; Williams DL; Angelucci F
    ACS Infect Dis; 2021 Jul; 7(7):1932-1944. PubMed ID: 33950676
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A 1,536-well-based kinetic HTS assay for inhibitors of Schistosoma mansoni thioredoxin glutathione reductase.
    Lea WA; Jadhav A; Rai G; Sayed AA; Cass CL; Inglese J; Williams DL; Austin CP; Simeonov A
    Assay Drug Dev Technol; 2008 Aug; 6(4):551-5. PubMed ID: 18665782
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative modeling of thioredoxin glutathione reductase from Schistosoma mansoni: a multifunctional target for antischistosomal therapy.
    Sharma M; Khanna S; Bulusu G; Mitra A
    J Mol Graph Model; 2009 Feb; 27(6):665-75. PubMed ID: 19070522
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Potent Inhibitors of Thioredoxin Glutathione Reductase: Grail of Anti-Schistosome Drug within Reach?
    Tripathi T; Chetri PB
    ACS Infect Dis; 2020 May; 6(5):893-895. PubMed ID: 32159329
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structure mechanism insights and the role of nitric oxide donation guide the development of oxadiazole-2-oxides as therapeutic agents against schistosomiasis.
    Rai G; Sayed AA; Lea WA; Luecke HF; Chakrapani H; Prast-Nielsen S; Jadhav A; Leister W; Shen M; Inglese J; Austin CP; Keefer L; Arnér ES; Simeonov A; Maloney DJ; Williams DL; Thomas CJ
    J Med Chem; 2009 Oct; 52(20):6474-83. PubMed ID: 19761212
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.